3 ms·
It mat not be only the safety profile, but also the fact that drug patent has expired in 2016. I am sure they’ll come up with an alternative that may have simi
by thowaway1001 6y ago
It mat not be only the safety profile, but also the fact that drug patent has expired in 2016.
I am sure they’ll come up with an alternative that may have similar or better safety profile and could pay for clinical trials.
No company is going to finance Phase 3 trial on patent free drug.
- justinclift 6y agoAre you meaning the expiry of the 1999/2000 patents? There seem to be several others, including some filed recently: https://www.drugpatentwatch.com/p/generic-api/BEXAROTENE https://www.drugpatentwatch.com/p/generic-api/BEXAROTENE On a side note, is anyone aware of better info source that "drugpatentwatch.com"? That site seems to lock useful info behind a paywall.